ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 223 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $182 | -99.9% | 23,824 | -22.5% | 0.02% | -27.3% |
| Q3 2022 | $219,000 | -0.5% | 30,750 | +13.3% | 0.02% | 0.0% |
| Q2 2022 | $220,000 | -26.7% | 27,140 | +154.1% | 0.02% | -8.3% |
| Q1 2022 | $300,000 | 0.0% | 10,679 | 0.0% | 0.02% | 0.0% |
| Q4 2021 | $300,000 | -71.2% | 10,679 | -65.2% | 0.02% | -74.2% |
| Q3 2021 | $1,043,000 | -16.8% | 30,679 | 0.0% | 0.09% | -17.7% |
| Q2 2021 | $1,254,000 | +24.5% | 30,679 | +22.7% | 0.11% | +14.1% |
| Q1 2021 | $1,007,000 | -31.9% | 25,000 | 0.0% | 0.10% | -37.7% |
| Q4 2020 | $1,478,000 | +2.7% | 25,000 | -15.5% | 0.16% | -14.1% |
| Q3 2020 | $1,439,000 | +0.5% | 29,596 | 0.0% | 0.18% | -8.0% |
| Q2 2020 | $1,432,000 | +74.2% | 29,596 | 0.0% | 0.20% | +29.7% |
| Q1 2020 | $822,000 | -29.9% | 29,596 | -25.3% | 0.16% | -16.7% |
| Q4 2019 | $1,172,000 | – | 39,596 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,377,665 | $12,958,274 | 12.23% |
| Eagle Health Investments LP | 1,214,860 | $6,620,987 | 1.46% |
| Matrix Capital Management Company, LP | 11,572,590 | $63,070,616 | 0.76% |
| Aristotle Atlantic Partners, LLC | 3,058,206 | $16,667,223 | 0.67% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $163,465,709 | 0.66% |
| Pier Capital, LLC | 719,067 | $3,918,915 | 0.63% |
| DDD Partners, LLC | 783,697 | $3,385,571 | 0.49% |
| ARK Investment Management | 11,509,308 | $62,725,728 | 0.48% |
| Nikko Asset Management Americas, Inc. | 6,570,939 | $35,680,199 | 0.43% |
| Triatomic Management LP | 102,889 | $560,745 | 0.39% |